Alprazolam

Active ingredient description

Alprazolam, like other benzodiazepines, has a high affinity for the benzodiazepine binding site in the brain. It facilitates the inhibitory neurotransmitter action of gamma-aminobutyric acid, which mediates both pre- and post synaptic inhibition in the central nervous system (CNS).

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Alprazolam
N Nervous system → N05 Psycholeptics → N05B Anxiolytics → N05BA Benzodiazepine derivatives
Discover more medicines within N05BA12

Medicines

$substanceName is the active ingredient of these drugs:

Drug
Countries

Ecuador

Ecuador

Poland

Poland

Hong Kong

Estonia Lithuania

Austria

Australia Hong Kong

Finland Poland

Ecuador

Brazil

Ecuador

Brazil

Lithuania

Ireland

Australia Hong Kong

Cyprus Hong Kong

Poland

South Africa

Tunisia

South Africa

Cyprus

Germany

Brazil

Spain

Brazil

Canada Cyprus Ecuador Estonia France

Austria Finland South Africa

Singapore

Cyprus Hong Kong

Lithuania Poland

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Summary of Product Characteristics (SPC)
UK

Structural formula

Graphic representation of the active ingredient's molecular structure

Molecular mass: 308.765 g/mol

3D molecular structure

3D representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 28981-97-7
DrugBank Drug: DB00404
KEGG Drug: D00225
RxNorm Ingredient: 596
SNOMED-CT Concept: 386983007
Alprazolam (substance)
UNII Identifier: YU55MQ3IZY
ALPRAZOLAM